Stocks and Investing Stocks and Investing
Mon, October 17, 2022
Sat, October 15, 2022
Fri, October 14, 2022
Thu, October 13, 2022

Paul Matteis Upgraded (BIIB) to Strong Buy and Held Target at $299 on, Oct 13th, 2022


Published on 2024-10-27 23:21:49 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Held Target at $299 on, Oct 13th, 2022.

Paul has made no other calls on BIIB in the last 4 months.



There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 4 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $275 on, Friday, October 7th, 2022
  • Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $275 on, Friday, September 30th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $280 on, Wednesday, September 28th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $217 on, Wednesday, September 28th, 2022


These are the ratings of the 11 analyists that currently disagree with Paul


  • Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, October 7th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $309 on, Thursday, October 6th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $321 on, Wednesday, September 28th, 2022
  • Brian Skorney of "Baird" Upgraded from Hold to Buy and Increased Target to $340 on, Wednesday, September 28th, 2022
  • Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $360 on, Wednesday, September 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $350 on, Wednesday, September 28th, 2022
  • Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $270 on, Wednesday, September 28th, 2022
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, September 22nd, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $250 on, Thursday, July 21st, 2022
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $270 on, Thursday, July 21st, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $230 on, Monday, July 18th, 2022